Ultragenyx Pharmaceutical Inc. (RARE) Misses Q2 EPS by 3c
Tweet
Share
E-mailGet Alerts RARE Hot Sheet
Join SI Premium – FREE
Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) reported Q2 EPS of ($0.45), $0.03 worse than the analyst estimate of ($0.42).
For earnings history and earnings-related data on Ultragenyx Pharmaceutical Inc. (RARE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
- Eos Energy Enterprises (EOSE) PT Lowered to $5 at B.Riley
- Cheetah Net Supply Chain Service Inc. (CTNT) Reports Q2 EPS of $0.04
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
